BSEBoard Meeting31 Oct 2026 · 31 Oct 2026, 06:50 pm

Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company will be held on Wednesday, 4th November, 2026 at 5:00 P.M. at the Registered Office of the Company situated ....

Dipna Pharmachem Ltd · 543594

✦ AI SummaryResults

Dipna Pharmachem Ltd has informed BSE about a Board Meeting scheduled on 4th November, 2026 to consider unaudited financial results for the quarter ended 30th June, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Dipna Pharmachem Ltd - 543594 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Wednesday 4Th November, 2026

Attachments (1)

📄

dd8e05a2-c2b5-4dcd-b50b-ca18d5a046e1.pdf

pdf

Download →
View document text
DIPNA PHARMACHEM LIMITED CIN: L24100GJ2011PLC066400 Regd. Office: A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad – 380 055 E-mail: dharachem99@yahoo.in Date: 31st October, 2026 BSE Limited Phiroze Jeejeebhoy Tower, Dalal Street, Mumbai – 400 001 Dear Sir / Madam, Subject: Intimation of Board Meeting to be held on Wednesday 4th November, 2026 Ref: Security Id: DPL / Code: 543594 Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company will be held on Wednesday, 4th November, 2026 at 5:00 P.M. at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad – 380 055 inter alia, to consider and discuss: 1. The Unaudited Financial Results of the Company for the Quarter ended on 30th June, 2026 along with Limited Review Report. 2. Any other matter to be discussed and consider with the permission of Chairperson of the Board Meeting. Kindly take the same in your records. Thanking You, For, Dipna Pharmachem Limited Keyur Shah Managing Director DIN: 03167258